Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid

被引:3
作者
Chakravarti, N
Saadati, HG
El-Naggar, AK
Lotan, R
Diba, RE
Esmaeli, B [1 ]
机构
[1] Univ Texas, MD Anderson Canc Ctr, Sect Ophthalmol, Dept Plast Surg, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
关键词
D O I
10.1097/01.iop.0000172180.94824.79
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To study retinoid receptor expression in sebaceous cell carcinoma of the eyelid Methods: Expression of retinoid receptors (RAR alpha, beta, and gamma and RXR alpha, beta, and gamma) in tumor specimens from 10 patients with sebaceous cell carcinoma of the eyelid and in 3 normal incidental tarsus specimens from healthy adults without cancer was studied immunohistochemically by using antiretinoid receptor antibodies. Results: In all 3 specimens of normal tarsus, all 6 retinoid receptors were expressed. RAR alpha expression was absent in 3 tumors and was decreased in 3 tumors compared with expression in the control tissues. RAR beta expression in carcinomas was primarily perinuclear; 6 tumors showed increased RAR beta expression compared with controls. RAR gamma expression was absent in 4 tumors and was decreased in 2 tumors compared with controls. RXR alpha nuclear expression was decreased compared with controls in 5 tumors. RXR beta expression was low in 7 tumors. RXR gamma expression was absent in 6 tumors. Conclusions: Aberrant expression of retmoid receptors in sebaceous cell carcinoma of the eyelid might play a role in the pathogenesis and progression of this carcinoma.
引用
收藏
页码:292 / 297
页数:6
相关论文
共 43 条
[41]  
Wurzer G, 2001, J CELL BIOCHEM, P1
[42]   Suppression of retinoic acid receptor beta in non-small-cell lung cancer in vivo: Implications for lung cancer development [J].
Xu, XC ;
Sozzi, G ;
Lee, JS ;
Lee, JJ ;
Pastorino, U ;
Pilotti, S ;
Kurie, JM ;
Hong, WK ;
Lotan, R .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09) :624-629
[43]  
Xu XC, 2001, CANCER RES, V61, P4306